A variant in MCF2L is associated with osteoarthritis
- PMID: 21871595
- PMCID: PMC3169824
- DOI: 10.1016/j.ajhg.2011.08.001
A variant in MCF2L is associated with osteoarthritis
Abstract
Osteoarthritis (OA) is a prevalent, heritable degenerative joint disease with a substantial public health impact. We used a 1000-Genomes-Project-based imputation in a genome-wide association scan for osteoarthritis (3177 OA cases and 4894 controls) to detect a previously unidentified risk locus. We discovered a small disease-associated set of variants on chromosome 13. Through large-scale replication, we establish a robust association with SNPs in MCF2L (rs11842874, combined odds ratio [95% confidence interval] 1.17 [1.11-1.23], p = 2.1 × 10(-8)) across a total of 19,041 OA cases and 24,504 controls of European descent. This risk locus represents the third established signal for OA overall. MCF2L regulates a nerve growth factor (NGF), and treatment with a humanized monoclonal antibody against NGF is associated with reduction in pain and improvement in function for knee OA patients.
Copyright © 2011 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Figures



References
-
- Valdes A.M., Spector T.D. Genetic epidemiology of hip and knee osteoarthritis. Nat Rev Rheumatol. 2011;7:23–32. - PubMed
-
- Evangelou E., Valdes A.M., Kerkhof H.J., Styrkarsdottir U., Zhu Y., Meulenbelt I., Lories R.J., Karassa F.B., Tylzanowski P., Bos S.D., arcOGEN Consortium. Translation Research in Europe Applied Technologies for Osteoarthritis (TreatOA) Meta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22. Ann. Rheum. Dis. 2011;70:349–355. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical